隴神戎發(300534.SZ)收到“2019年度甘肅省技術創新引導計劃(第三批)”專項資金200萬元
格隆匯12月31日丨隴神戎發(300534.SZ)公佈,公司於2019年12月30日收到甘肅省財政廳撥付給公司“2019年度甘肅省技術創新引導計劃(第三批)”專項資金人民幣200萬元,該筆資金為公司根據甘肅省科技廳《關於開展2019年促成技術交易及轉移轉化科技成果獎勵的通知》(甘科成函〔2019〕26號)申請獲得。上述政府補助資金與收益相關,計入其他收益科目,佔公司2018年度經審計的歸屬於上市公司股東淨利潤的16.29%,補助形式為貨幣資金,資金已到賬,且與公司日常經營活動相關,不具有可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.